- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.11. | Sandoz launches first biosimilar Tysabri in US | ||
| 17.11. | J&J swoops on cancer biotech Halda with $3bn takeover deal | ||
| 17.11. | BMS, J&J give up on milvexian for acute coronary syndrome | ||
| 17.11. | Filmmaker helps AbbVie spread the word about leukaemia | ||
| 17.11. | Sofinnova Partners raises €650m for early-stage biotechs | ||
| 17.11. | Sarepta rises after FDA adds warning label to Elevidys | ||
| 14.11. | Sanofi's type 1 diabetes drug poised for EU rollout | ||
| 14.11. | Lundbeck makes bid for Avadel, trying to displace Alkermes | ||
| 14.11. | Kura scores FDA okay for rival to Syndax's leukaemia drug | ||
| 14.11. | Update: MSD's $9.2bn deal for flu biotech Cidara confirmed | ||
| 14.11. | Medicxi raises €500m for latest biotech fund | ||
| 14.11. | Medicxi raises €500m for fifth biotech fund | ||
| 14.11. | MSD said to be close to $9bn+ deal for flu biotech Cidara | ||
| 13.11. | NICE backs Roche's non-Hodgkin lymphoma drug Columvi | ||
| 13.11. | AbbVie exits alliance with Alphabet biotech Calico; report | ||
| 13.11. | Novartis says novel drug could counter malaria resistance | ||
| 13.11. | FDA unveils swift route to market for personalised drugs | ||
| 13.11. | Change at the top of Recursion as co-founder leaves CEO role | ||
| 12.11. | One Drop founder announces broad market CGM on Frontiers stage | ||
| 12.11. | Alkermes breaks new ground in narcolepsy with orexin drug | ||
| 12.11. | Bayer beats expectations with tougher times looming | ||
| 12.11. | AI features in UK plan to reduce animal testing | ||
| 12.11. | NHS braces for thousands of redundancies | ||
| 12.11. | FDA appoints veteran Pazdur to replace Tidmarsh | ||
| 11.11. | Trial sets up filing for enGene bladder cancer gene therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .